How Big Pharma Profits Stack Up Against Other Industries
Executive Summary
Research published in JAMA shows that the pharmaceutical industry outpaces other industries in the S&P 500 on several measures of profitability.
You may also be interested in...
JAMA Drug Pricing Studies: Moving The Needle Or Looking At The Past?
Studies show net prices increases, R&D spending lower than often cited, and better profit margins other industries. But pharma pushes back with concerns about study designs and maintains the picture has changed in more recent years.
The Cost To Bring A New Drug To Market? $1.3bn, JAMA Study Finds
The mean R&D investment required to bring a new drug to market was $1.3bn in a new study estimating pharma R&D costs, lower than the $2.8bn frequently cited from a prior study.
How The Coronavirus Could Bolster Innovation Arguments Against US Price Controls
The Trump administration does not believe its partnership with industry on therapeutics for COVID-19 should include conditions on pricing, US Health Secretary Alex Azar tells Congress.